Nuzenio

Theriva

Theriva news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT Theriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - MinichartMinichart · Thu, 06 Aug 2026 18:27:00 GMT Theriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock TitanStock Titan · Thu, 06 Aug 2026 12:11:14 GMT Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMT Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT Theriva Biologics (NYSE American: TOVX) holders back bigger stock plan, warrants - Stock TitanStock Titan · Tue, 04 Aug 2026 11:20:42 GMT Theriva Biologics, Inc. Revenue Breakdown – AMEX:TOVX - TradingViewTradingView · Sat, 01 Aug 2026 05:47:20 GMT Theriva Biologics Inc (TOVX) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial Vanguard

Thu, 06 Aug 2026 18:27:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - Minichart

Thu, 06 Aug 2026 12:11:14 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock Titan

Thu, 06 Aug 2026 12:00:00 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswire

Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock Titan

Tue, 04 Aug 2026 11:20:42 GMTTheriva Biologics (NYSE American: TOVX) holders back bigger stock plan, warrants - Stock Titan

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

TOVX10 live mentions Trial4 live mentions Metastatic Pancreatic Cancer4 live mentions Phase4 live mentions NYSE American4 live mentions Inc4 live mentions Revenue Breakdown4 live mentions Theriva Biologics Inc4 live mentions Theriva Biologics3 live mentions Stock Titan Theriva3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Theriva.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.